Search
forLearn
5 / 801 resultslearn Vascular Endothelial Growth Factor
learn riboflavin
learn valine
learn AHAs
Research
5 / 25 results
research Endovascular treatment of scalp AVF following hair transplantation: case report
The conclusion is that treating scalp AVF caused by hair transplantation with endovascular methods like coiling is safe and effective.
research Scalp Arteriovenous Fistula Following Hair Transplantation
A man developed a rare blood vessel connection on his scalp after hair transplants, which was successfully treated with surgery.
research Scalp Arteriovenous Fistula following Hair Transplantation: A Case Report and Review of the Literature
Hair transplants are usually safe but can rarely cause scalp AVF, which can be effectively treated with surgery or endovascular methods.
research Retrospective clinical study on the efficacy and complications of interventional embolization in the treatment of scalp arteriovenous fistula
Interventional embolization is effective for treating scalp arteriovenous fistula but can cause complications like swelling and hair loss.
research Traumatic scalp arteriovenous fistula post capillary implantation successfully treated using PHIL embolic agent
A scalp blood vessel issue from hair transplant was successfully treated with a special liquid agent.
Community Join
5 / 1000+ resultscommunity Alfatradiol as a base for Topical Finasteride
User creates 0.1% topical finasteride solution using Alfatradiol Avixis base. Seeks help to ensure alfatradiol base dissolves finasteride.
community where and how to do Verteporfin after HT
community Verteporfin FUT 9 Month Update
Dr. Bloxham's 9-month update on FUT scar revision with Verteporfin shows promising results. Excitement is high for FUE, which appears highly effective based on Dr. Barghouthi's findings.
community There's a Dr wanting to expand his Verteporfin trials
Verteporfin may improve hair transplant outcomes and reduce scarring, potentially allowing patients to avoid finasteride. Dr. Barghouthi seeks collaborations, volunteers, and financial support for research on verteporfin.org.
community AH-001 another topical AR degrader beside GT20029, completed Phase I
AH-001 is a new topical treatment designed to degrade androgen receptors, targeting the root cause of androgenetic alopecia without the side effects of oral treatments like finasteride. It has shown a strong safety profile and good local tolerability in early trials.